Update on InnomarClinics
InnomarClinics remain open to our patients amidst coronavirus (COVID-19) concerns.
Innomar Strategies Enhances Market Access Expertise with Acquisition of Wyatt Health Management
February 16, 2017
OAKVILLE, Ontario – Innomar Strategies, Canada’s leading specialty pharmaceuticals service provider and a part of AmerisourceBergen, announced today the acquisition of reimbursement consulting firm Wyatt Health Management. Together, Wyatt Health Management and Innomar Strategies’ existing strategic consulting arm will form InnomarConsulting™, a full-service specialty market consultancy. This acquisition further reinforces Innomar Strategies’ position as an expert on public and private payer reimbursement in Canada’s specialty marketplace and will expand its patient support services with industry-leading commercialization offerings.
For the past 15 years, Wyatt Health Management has gained a leadership position in the Canadian healthcare and reimbursement environment, and served as key expert in providing market access insights to specialty pharmaceutical manufacturers. Its suite of data and proprietary predictive products – which includes the CDR Tracker®, pCODR Tracker® and CDR Forecaster™ – provides companies with the facts and foresight to strategically commercialize within the Canadian marketplace.
“We are excited by the opportunity to bring the talent of Wyatt Health Management into Innomar Strategies, ultimately enhancing our consulting solutions for current and future customers,” said Guy Payette, President, Innomar Strategies. “Together, our new combination of resources, experts and thought-leadership will provide an enhanced market access consulting service to best meet the evolving needs throughout the Canadian commercialization journey.”
George Wyatt, Managing Director and Founder of Wyatt Health Management, will join InnomarConsulting. Wyatt brings more than 30 years of industry experience to the company. Accompanying Wyatt is his team of renowned experts who will support InnomarConsulting in the key areas of market access submissions, health economic outcomes research and reimbursement strategy.
Innomar Strategies offers a broad suite of customized, end-to-end commercialization solutions, including market access consulting, patient support programs, nursing and clinic services, and specialty pharmacy and logistics management.
About Innomar Strategies
Innomar Strategies, a part of AmerisourceBergen, is the leading patient support provider in the Canadian specialty biopharmaceutical market. We deliver end-to-end commercialization solutions to improve product access, increase supply chain efficiency and enhance patient care. Strategic consulting, patient support programs, nursing and clinical services, and specialty pharmacy and logistics are just a few of our key areas of specialization. We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment to best-in-class care, Innomar Strategies helps navigate the patient journey to optimize health outcomes. Visit us at www.innomarstrategies.com.
AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health. With over $145 billion in annual revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 19,000 people. AmerisourceBergen is ranked #12 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.